Product Information

TIMOLOL MALEATE 0.25% EYE DROP is a generic product labeled by Rising Pharma Holdings Inc., priced at $0.6532 per ML under NDC 64980051301. Its NADAC has been published 592 times since Jul 15, 2015.

FDA first approved this application on Apr 30, 2008. Its Orange Book therapeutic-equivalence code is AT1.

TIMOLOL MALEATE 0.25% EYE DROP

timolol maleate
$0.6532per ML

Strength

2.5 mg/mL

NDC

64980051301

Classification

Generic

Dosage Form

SOLUTION/ DROPS

Route

OPHTHALMIC

Effective Date

10/21/2026

Active Ingredients

TIMOLOL MALEATE

Approval Type

Generic (ANDA)

FDA Application

ANDA077259

FDA Approved

4/30/2008

TE Code

AT1

On Market Since

12/15/2014

Pharmacological Classes

Adrenergic beta-Antagonists
beta-Adrenergic Blocker

Price Statistics

The NADAC for TIMOLOL MALEATE 0.25% EYE DROP has been published 592 times since Jul 15, 2015, and over the history we have for it it has risen 16.7%. The table below summarizes its recorded NADAC range and movement.

Current price$0.6532 per ML
All-time high$1.0508 (Apr 12, 2023)
All-time low$0.4018 (Dec 19, 2018)
52-week high$0.6534
52-week low$0.6148
Median price$0.6148
Average price$0.6187
Largest weekly change+42.6% (Mar 18, 2020)
Weeks tracked592
Tracking sinceJul 15, 2015

Price History

1W

0.0%

1M

+1.0%

3M

+6.2%

6M

+6.1%

1Y

+4.8%

3Y

-12.8%

5Y

-16.6%

All

+16.7%

Generic Alternatives

The matcher finds 3 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). Switching to the cheapest would cut per-unit acquisition cost by roughly 7% at current NADAC. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.

Continue researching this drug

Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.

Frequently asked questions

What is the NADAC price of TIMOLOL MALEATE 0.25% EYE DROP?

The current National Average Drug Acquisition Cost (NADAC) for TIMOLOL MALEATE 0.25% EYE DROP, manufactured by Rising Pharma Holdings Inc., is $0.6532 per ML (NDC 64980051301), effective Nov 11, 2026.

How has the price of TIMOLOL MALEATE 0.25% EYE DROP changed over time?

Over the history we have for it, the NADAC for TIMOLOL MALEATE 0.25% EYE DROP has risen 16.7%. It has been tracked across 592 weekly CMS publications since Jul 15, 2015.

What are the highest and lowest recorded NADAC prices for TIMOLOL MALEATE 0.25% EYE DROP?

Since Jul 15, 2015, the NADAC for TIMOLOL MALEATE 0.25% EYE DROP has ranged from a low of $0.4018 (Dec 19, 2018) to a high of $1.0508 (Apr 12, 2023), with a median of $0.6148 per ML.

Are there cheaper alternatives to TIMOLOL MALEATE 0.25% EYE DROP?

Yes. 3 manufacturers publish a NADAC-priced product with the same active ingredient and strength in a comparable dosage form. The lowest-priced option, TIMOLOL MALEATE 0.25% EYE DROP, is $0.6051 per ML — about 7% below TIMOLOL MALEATE 0.25% EYE DROP.

Who manufactures TIMOLOL MALEATE 0.25% EYE DROP?

TIMOLOL MALEATE 0.25% EYE DROP (NDC 64980051301) is labeled by Rising Pharma Holdings Inc., and CMS classifies it as a generic product.